KPV

KPV—short for Lysine-Proline-Valine—is a synthetic tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It is primarily studied in preclinical laboratory research involving inflammatory-response pathways, cellular signalling and tissue biology. Animal-model research has investigated KPV in areas such as intestinal inflammation, but established human clinical evidence remains unavailable.

Product Features

• Synthetic three-amino-acid research peptide
• Suitable for controlled laboratory and analytical studies
• Commonly investigated in inflammatory-response research
• Supplied in securely sealed and clearly labelled packaging
• Intended for handling by qualified research professionals

Research Applications

KPV may be investigated in laboratory settings involving:

• Cellular inflammatory signalling
• Melanocortin-related biological pathways
• Gastrointestinal and epithelial research
• Cellular migration and tissue-response models
• Comparative peptide analysis

Storage

Store according to the conditions stated on the product label or certificate of analysis. Keep the container securely sealed and protected from excessive heat, moisture and direct sunlight.

Important Notice

KPV is not an FDA-approved medicine. As of April 22, 2026, the FDA stated that it had not identified human-exposure data for drug products containing KPV and lacked sufficient information to determine its safety in humans.

This product must not be promoted as a treatment for inflammation, wounds, digestive conditions, skin conditions or any other medical purpose.

For laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.